肺癌一个新的诊断因子？
http://www.100md.com
2003年9月27日
In the current issue of British Journal of Cancer, Meert and colleagues have analysed the results of 30 studies, published between 1990 and 2002, that evaluated lung cancer, the association between c-erbB-2 status and survival, and the measure of c-erbB-2 expression in the tumour. After aggregation of the available survival results of lung cancer patients according to the tumour expression of c-erbB-2, the presence of this receptor appears to be a potential prognostic factor for worse survival in non-small cell lung cancer.
review
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
A-P MEERT, B MARTIN, M PAESMANS, T BERGHMANS, C MASCAUX, J-M VERDEBOUT, P DELMOTTE, J-J LAFITTE & J-P SCULIER
British Journal of Cancer 89, 959- 965; 15 September 2003
| Abstract | Full Text (HTML/PDF) |, http://www.100md.com
review
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
A-P MEERT, B MARTIN, M PAESMANS, T BERGHMANS, C MASCAUX, J-M VERDEBOUT, P DELMOTTE, J-J LAFITTE & J-P SCULIER
British Journal of Cancer 89, 959- 965; 15 September 2003
| Abstract | Full Text (HTML/PDF) |, http://www.100md.com